Fidelity Investments
SKIN icon

Fidelity Investments’s SkinHealth Systems SKIN Stock Holding History

Fidelity Investments’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.06M Sell
10,201,685
-6,981,546
-41% -$5.34M ﹤0.01% 2281
2026
Q1 		$15.3M Sell
17,183,231
-1,087,569
-6% -$1.34M ﹤0.01% 1888
2025
Q4 		$25.4M Sell
18,270,800
-98,675
-0.5% -$143K ﹤0.01% 1687
2025
Q3 		$36.6M Sell
18,369,475
-153,367
-0.8% -$311K ﹤0.01% 1553
2025
Q2 		$35.4M Sell
18,522,842
-211,559
-1% -$298K ﹤0.01% 1509
2025
Q1 		$25.1M Buy
18,734,401
+116,078
+0.6% +$177K ﹤0.01% 1605
2024
Q4 		$29.6M Buy
18,618,323
+15,286
+0.1% +$24K ﹤0.01% 1588
2024
Q3 		$26.8M Buy
18,603,037
+58,826
+0.3% +$96.4K ﹤0.01% 1617
2024
Q2 		$35.6M Sell
18,544,211
-1,113,426
-6% -$3.14M ﹤0.01% 1443
2024
Q1 		$87.3M Buy
19,657,637
+2,871,452
+17% +$9.33M 0.01% 1112
2023
Q4 		$52.2M Sell
16,786,185
-3,146,680
-16% -$11.8M ﹤0.01% 1277
2023
Q3 		$120M Buy
19,932,865
+35,038
+0.2% +$246K 0.01% 896
2023
Q2 		$167M Buy
19,897,827
+22,820
+0.1% +$237K 0.01% 792
2023
Q1 		$251M Sell
19,875,007
-2,757,678
-12% -$31.9M 0.02% 621
2022
Q4 		$206M Sell
22,632,685
-308
-0% -$3.33K 0.02% 668
2022
Q3 		$267M Buy
22,632,993
+38,242
+0.2% +$483K 0.03% 571
2022
Q2 		$291M Buy
22,594,751
+5,044
+0% +$67.6K 0.03% 563
2022
Q1 		$381M Buy
22,589,707
+143,665
+0.6% +$2.37M 0.03% 534
2021
Q4 		$542M Buy
22,446,042
+2,433,170
+12% +$62.7M 0.04% 430
2021
Q3 		$520M Buy
20,012,872
+310,880
+2% +$6.84M 0.04% 416
2021
Q2 		$309M Buy
19,701,992
+12,801,992
+186% +$175M 0.02% 642
2021
Q1 		$74.5M Buy
6,900,000
+4,579,221
+197% +$50.4M 0.01% 1210
2020
Q4 		$26.2M Buy
+2,320,779
New +$25M ﹤0.01% 1591

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $773M AUM 8.9% 1-Year Est. Return

Fidelity Investments's SKIN Position: Q2 2026 in Review

Fidelity Investments reduced its SkinHealth Systems (SKIN) stake by 41% in Q2 2026, selling an estimated $5.34M and leaving 10,201,685 shares worth $7.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2281.

Fidelity Investments first reported a position in SKIN in Q4 2020 and has held it in 23 quarters since. The position peaked at $542M in Q4 2021. 94 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • Fidelity Investments held 10,201,685 shares of SkinHealth Systems worth $7.06M as of Q2 2026.
  • Fidelity Investments sold 6,981,546 SkinHealth Systems shares in Q2 2026, an estimated $5.34M.
  • SkinHealth Systems made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2281 holding.
  • Fidelity Investments first reported a position in SkinHealth Systems in Q4 2020 and has held it in 23 quarters since.
  • Fidelity Investments's SkinHealth Systems position peaked at $542M in Q4 2021.
  • 94 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.